Breakthrough Victoria invests in Melbourne-based company ‘with a nose for innovation’
Independent investment company Breakthrough Victoria is investing $800,000 in Diag-Nose.io Medical (DNM), a Melbourne based ...
Tectonic Therapeutic: Stock Spikes On Heart Failure Data -- Why I See Further Upside
Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...
American Association of Individual Investors1d
Which Is a Better Investment, The Ensign Group, Inc. or Privia Health Group, Inc. Stock?
Learn more about whether The Ensign Group, Inc. or Privia Health Group, Inc. is a better investment based on AAII's A+ ...
manilatimes5d
aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
Current epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. based on real-world evidence ...
manilatimes4d
Diag-Nose.io Expands to Bethlehem, PA, Following Oversubscribed $2M Seed Round Funding to Revolutionize Respiratory Diagnostics
A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...
Le Lézard6d
Cyngn Signs Contract to Deploy DriveMod Tugger at a Major Consumer Packaged Goods Company
Cyngn announced that it will be deploying its DriveMod Tugger at a major Consumer Packaged Goods (CPG) distribution company.
expresshealthcare6d
Leveraging AI for predictive analytics in chronic disease management
Subhro Mallik highlights the transformative role of AI and predictive analytics in chronic disease management, offering early ...
Hendersonville Times-News on MSN3d
Pardee BlueMD opens primary care practice in Arden, using physician-pharmacist co-visit model
Pardee BlueMD opens new primary care practice in Arden, using a physician-pharmacist co-visit model to offer more thorough ...
Home Health Care News5d
How Amedisys, SSM Achieve Success With Disease-Specific Care Models
As the demand for personalized and effective health care solutions grows, home health care providers are implementing more ...
Le Lézard5d
XORTX to Present at Microcap Conference
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease and gout, announces ...
Startup Daily1d
Respiratory care biotech Diag-Nose sniffs out $3.15 million Seed round
Diag-Nose.io hopes to transform management of chronic respiratory diseases globally using its AI-powered biomarker diagnostic ...